phone iconPhone: (401) 822-4673
phone iconFax: (401) 822-4676
Receive our Health e-Newsletter

News for Healthier Living

Drug From Stony Brook-Developed Anti-Cancer Compounds Now in Clinical Trials

A promising new cancer chemotherapeutic agent from a taxane class of natural compounds - anti-cancer agents designed to block cell division and trigger the programmed cell death to treat sold tumors - originally developed by researchers at Stony Brook University has entered human clinical trials.

November 5, 2026


November 15 2026

November 13 2026

November 12 2026

November 11 2026

November 10 2026

November 9 2026

November 8 2026

November 7 2026

November 6 2026

November 5 2026

November 4 2026

November 3 2026

November 2 2026

November 1 2026

Angell Street Psychiatry
Copyright 2026 HealthBanks, Inc. All rights reserved.
Terms of Use | Privacy Policy